Rexulti: Uses, Drug Class, Alternatives, and More

Rexulti is the brand name for brexpiprazole, a prescription medication used for certain mental health and dementia-related symptoms. It is not a “take one and instantly feel like a motivational poster” kind of medicine. Instead, it works gradually, usually as part of a bigger treatment plan that may include antidepressants, therapy, family support, sleep repair, careful monitoring, and, ideally, fewer late-night symptom Googling sessions.

Doctors may prescribe Rexulti for adults with major depressive disorder when an antidepressant alone is not doing enough, for schizophrenia in adults and adolescents ages 13 and older, and for agitation associated with dementia due to Alzheimer’s disease. Because Rexulti affects brain chemicals involved in mood, thinking, and behavior, it can be usefulbut it also deserves respect. Like other antipsychotic medications, it can cause side effects and carries important boxed warnings.

This guide explains what Rexulti is used for, what drug class it belongs to, how it works, possible alternatives, common side effects, and practical experience-based tips for discussing it with a healthcare professional.

What Is Rexulti?

Rexulti is an oral tablet taken once daily, with or without food. Its active ingredient, brexpiprazole, belongs to a group of medications called atypical antipsychotics, also known as second-generation antipsychotics. These medications are called “atypical” not because they wear tiny sunglasses indoors, but because they differ from older antipsychotics in how they affect dopamine, serotonin, and other receptors in the brain.

Rexulti is sometimes described as a serotonin-dopamine activity modulator. In everyday language, that means it helps adjust certain brain signaling systems rather than simply turning them “on” or “off.” It has partial activity at dopamine D2 and serotonin 5-HT1A receptors and blocking activity at serotonin 5-HT2A receptors. These actions may help with mood, psychosis, irritability, and agitation in specific conditions.

What Is Rexulti Used For?

1. Add-On Treatment for Major Depressive Disorder

For adults with major depressive disorder, Rexulti is approved as an add-on treatment to an antidepressant. This is called adjunctive therapy. In plain English: the antidepressant is still the main character, and Rexulti may join the cast when the original plot is not moving forward.

A clinician may consider Rexulti when someone has taken an antidepressant as prescribed but still has lingering symptoms such as low mood, loss of interest, fatigue, hopelessness, poor concentration, or emotional heaviness. Rexulti is not usually the first medication tried for depression. It is more commonly considered after standard antidepressant treatment has provided only partial relief.

2. Treatment of Schizophrenia

Rexulti is also approved to treat schizophrenia in adults and pediatric patients ages 13 years and older. Schizophrenia can involve hallucinations, delusions, disorganized thinking, reduced motivation, social withdrawal, and difficulty functioning day to day.

Antipsychotic medications are a central part of schizophrenia treatment. Rexulti may help reduce psychotic symptoms and support longer-term stability, though the right medication varies from person to person. Some people respond well to one antipsychotic but not another, which is why treatment often involves careful dose adjustments and follow-up visits.

3. Agitation Associated With Dementia Due to Alzheimer’s Disease

Rexulti is approved to treat agitation associated with dementia due to Alzheimer’s disease. Agitation may include pacing, restlessness, verbal aggression, physical aggression, resistance to care, or severe emotional distress. These symptoms can be exhausting for both the person with dementia and their caregivers.

Important detail: Rexulti is not approved as an as-needed “PRN” medication for Alzheimer’s agitation. It is also not approved for dementia-related psychosis without agitation associated with Alzheimer’s disease. In dementia care, medication decisions should be especially cautious because older adults may be more sensitive to side effects such as sedation, dizziness, falls, stroke risk, and confusion.

Rexulti Drug Class: Is It an Antidepressant or Antipsychotic?

Rexulti is an atypical antipsychotic, not a traditional antidepressant. However, it can be used alongside antidepressants for adults with major depressive disorder. That is where confusion often happens. A person may say, “My doctor gave me Rexulti for depression, so it must be an antidepressant.” Not exactly. It is an antipsychotic used as an add-on depression treatment in certain cases.

This distinction matters because antipsychotic medications have different monitoring needs than standard antidepressants. Doctors may watch for changes in weight, blood sugar, cholesterol, movement symptoms, restlessness, sleepiness, blood pressure, and mood changes.

How Rexulti Works in the Brain

Rexulti affects neurotransmitters, especially dopamine and serotonin. Dopamine is involved in motivation, reward, movement, and psychosis-related symptoms. Serotonin is involved in mood, anxiety, sleep, appetite, and emotional regulation. Instead of acting like a hammer, Rexulti acts more like a dimmer switch on several receptor systems.

In depression, this may help improve mood when antidepressants alone are not enough. In schizophrenia, it may help reduce hallucinations, delusions, and disorganized thinking. In Alzheimer’s-related agitation, its effects on mood and behavior circuits may help reduce severe agitation, although it does not cure Alzheimer’s disease or reverse memory loss.

Common Side Effects of Rexulti

Not everyone experiences side effects, but they are possible. Commonly reported side effects include:

• Weight gain
• Sleepiness or fatigue
• Dizziness
• Restlessness or akathisia, which can feel like an inner motor that forgot where the off switch is
• Headache
• Common cold-like symptoms
• Insomnia or sleep changes
• Nausea or digestive discomfort

For people using Rexulti for agitation associated with Alzheimer’s dementia, commonly reported side effects may include headache, dizziness, urinary tract infection, nasopharyngitis, and sleep disturbances. Older adults should be monitored closely because even “mild” dizziness can become a serious fall risk.

Serious Warnings and Safety Concerns

Rexulti has boxed warnings. Elderly patients with dementia-related psychosis treated with antipsychotic drugs have an increased risk of death. Rexulti also carries a warning about increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults when used with antidepressants, especially early in treatment or after dose changes.

Other serious risks can include neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes such as high blood sugar or cholesterol, low white blood cell counts, seizures, low blood pressure when standing, falls, trouble swallowing, impulse-control problems, and allergic reactions. These risks sound dramatic because, medically speaking, they are the “read the label, do not wing it” section.

Anyone taking Rexulti should contact a healthcare professional right away for unusual muscle stiffness, fever, confusion, uncontrolled movements, fainting, severe restlessness, new or worsening depression, suicidal thoughts, signs of infection, extreme thirst, frequent urination, or sudden weakness, speech problems, or vision changes.

Rexulti Dosage: What to Know

Rexulti dosing depends on the condition being treated, age, other medications, liver or kidney function, and how well the person tolerates it. Doctors typically start with a low dose and increase slowly. This approach helps reduce side effects and gives the body time to adjust.

For depression, Rexulti is usually added to an antidepressant at a low starting dose. For schizophrenia, target doses are often higher. For agitation associated with Alzheimer’s dementia, the dose is usually increased gradually over several weeks. Never change the dose, stop suddenly, or restart Rexulti without medical guidance. Brains appreciate consistency; they do not enjoy surprise medication plot twists.

Who Should Be Extra Careful With Rexulti?

Before taking Rexulti, people should tell their healthcare provider about all medical conditions, including diabetes, high cholesterol, heart disease, low blood pressure, seizures, liver problems, kidney problems, low white blood cell counts, pregnancy, breastfeeding, or a history of compulsive behaviors. They should also share all prescription drugs, over-the-counter medications, vitamins, and supplements.

Drug interactions matter. Some medications can change how the body processes brexpiprazole, especially drugs that affect CYP2D6 or CYP3A4 enzymes. This may require dose adjustments. Alcohol and other sedating substances can also increase dizziness, sleepiness, and impaired judgment.

Rexulti Alternatives

The best alternative to Rexulti depends on why it was prescribed. A substitute for depression may not be the same as a substitute for schizophrenia or Alzheimer’s-related agitation.

Alternatives for Depression

For major depressive disorder, alternatives may include optimizing the current antidepressant dose, switching antidepressants, combining antidepressants, adding psychotherapy, or considering other add-on medications. Other atypical antipsychotics sometimes used as add-on depression treatments include aripiprazole, quetiapine XR, cariprazine, and lumateperone. Non-antipsychotic strategies may include lithium, thyroid hormone augmentation, transcranial magnetic stimulation, esketamine, or electroconvulsive therapy in appropriate cases.

Alternatives for Schizophrenia

For schizophrenia, possible alternatives include aripiprazole, risperidone, paliperidone, olanzapine, quetiapine, lurasidone, ziprasidone, cariprazine, lumateperone, and clozapine for treatment-resistant cases. Long-acting injectable antipsychotics may be helpful for people who struggle with daily pills. Supportive therapy, family education, supported employment, and coordinated specialty care can also improve outcomes.

Alternatives for Alzheimer’s-Related Agitation

For agitation in Alzheimer’s dementia, non-drug approaches are often tried first unless there is immediate danger. These can include checking for pain, infection, constipation, hunger, overstimulation, loneliness, poor sleep, medication side effects, or environmental triggers. Caregiver coaching, predictable routines, music, gentle activity, calming communication, and reducing noise can sometimes help more than expected.

When symptoms are severe or dangerous, clinicians may consider medication. Other antipsychotics have been used off-label for dementia-related behaviors, but they also carry serious risks. Decisions should be individualized and revisited regularly.

Rexulti vs. Abilify: How Are They Different?

Rexulti and Abilify are often compared because brexpiprazole and aripiprazole are related in how they affect dopamine and serotonin. Both can be used for schizophrenia and as add-on treatment for depression. However, they are not identical. Some people may experience more restlessness with one and more weight gain or sedation with another. The “better” option depends on symptoms, side effects, medical history, cost, insurance coverage, and previous medication response.

How Long Does Rexulti Take to Work?

Rexulti does not usually work overnight. Some people notice changes within the first couple of weeks, while others need several weeks after reaching a therapeutic dose. For depression, improvement may show up as slightly more energy, fewer dark thoughts, better emotional flexibility, or the ability to do basic tasks without feeling like climbing Mount Everest in flip-flops.

For schizophrenia, symptom changes may include fewer hallucinations, less suspiciousness, or clearer thinking. For Alzheimer’s agitation, caregivers may notice fewer intense episodes or easier redirection. If there is no benefit after an adequate trial, or side effects are difficult, the prescriber may adjust the plan.

Practical Experience: What Patients and Caregivers Often Notice

Experience with Rexulti can vary widely. One person may describe it as the missing puzzle piece after several antidepressants only helped halfway. Another may stop because of restlessness, weight gain, or sleepiness. That does not mean either person is “right” or “wrong.” Psychiatric medication response is personal, and the brain is not a vending machine where you press B7 and reliably receive emotional stability.

In depression care, people often talk about subtle early changes rather than a sudden burst of happiness. A realistic improvement might sound like, “I still have depression, but I answered emails today,” or “I got out of bed without negotiating with the ceiling for 45 minutes.” These small changes matter. They can signal that the treatment plan is beginning to help. However, any increase in agitation, impulsivity, suicidal thoughts, or severe restlessness should be reported quickly.

Some people taking Rexulti notice appetite changes before mood changes. This is why tracking weight, meals, movement, sleep, and energy can be useful. A simple weekly notenothing fancy, no glitter-covered wellness journal requiredcan help the prescriber see patterns. For example, if mood improves but weight climbs quickly, the doctor may discuss nutrition support, activity changes, lab monitoring, dose adjustment, or another medication.

For schizophrenia, the experience may involve balancing symptom control with side effects. A person might feel calmer and less overwhelmed but also more tired in the morning. Another might appreciate once-daily dosing because it is easier to remember. Families may notice changes before the patient does, such as fewer arguments about suspicious beliefs or better ability to follow a conversation. Still, medication is only one part of care. Stable housing, low-stress routines, therapy, community support, and respectful communication are not extras; they are part of the foundation.

Caregivers using Rexulti as part of an Alzheimer’s agitation plan may experience the medication differently because the goal is often safety and distress reduction, not “returning to normal.” A successful outcome may be fewer episodes of pacing, yelling, resistance to bathing, or fear-based aggression. But caregivers also need to watch for sleepiness, dizziness, falls, urinary symptoms, confusion, or changes in walking. In dementia care, the question is not only “Does it reduce agitation?” but also “Is the person safer, more comfortable, and still as alert as possible?”

Across all uses, the best experience tends to happen when patients, families, and clinicians communicate clearly. Helpful questions include: What symptom are we targeting? How will we measure success? What side effects should trigger a call? When should we follow up? What is the plan if this does not work? Medication decisions become less scary when everyone knows the map, even if the road has potholes.

Bottom Line

Rexulti is a prescription atypical antipsychotic used as an add-on treatment for major depressive disorder in adults, as a treatment for schizophrenia in adults and adolescents ages 13 and older, and for agitation associated with dementia due to Alzheimer’s disease. It may help when symptoms are serious or persistent, but it is not a casual medication and should be monitored carefully.

The most important takeaway is simple: Rexulti can be helpful for the right person, at the right dose, for the right reason. It can also cause side effects that deserve attention. Anyone considering Rexulti should discuss benefits, risks, alternatives, cost, monitoring, and personal treatment goals with a qualified healthcare professional.